EVOK - Evoke Pharma gets notice of allowance from united states patent and trademark office

Evoke Pharma (EVOK) announces that the United States Patent and Trademark Office ((USPTO)) issued a Notice of Allowance  for U.S. Application No. 16/181,841 for Gimoti (metoclopramide) nasal spray.The patent will cover methods of use for nasal delivery of metoclopramide for the treatment of gastroparesis."The issuance of this Notice of Allowance strengthens the intellectual property protection for Gimoti and will provide another Orange Book-listable patent and a significant addition to our intellectual property estate and overall marketing strategy for Gimoti," CEO Dave Gonyer said.Shares up more than 5% premarket.

For further details see:

Evoke Pharma gets notice of allowance from united states patent and trademark office